Thromboprophylaxis in Head and Neck Microvascular Reconstruction
- PMID: 29892322
- PMCID: PMC5993658
- DOI: 10.1055/s-0037-1607068
Thromboprophylaxis in Head and Neck Microvascular Reconstruction
Abstract
Head and neck patients undergoing microvascular reconstruction are at high risk for thromboembolism. While the prevention of thromboembolism has become an essential aspect of care, within the field of microsurgery, concern for anastomotic complications have hindered the creation of an accepted regimen. The aim of this review was to evaluate the risks and benefits of prophylactic agents for thromboprophylaxis. A literature search was conducted in MEDLINE, Cochrane Library, and PubMed/NCBI databases. Articles discussing thromboprophylaxis in otolaryngology, head and neck surgery, or microvascular reconstruction were considered in the review from the past 30 years. The majority of patients undergoing microvascular surgery have multiple risk factors for thrombus formation. Several consensus guidelines exist for the prophylaxis in patients who are critically ill, undergoing surgery, or with malignancy. Significant evidence supports the routine use of mechanical means, such as early mobilization and pneumatic compression along with subcutaneous heparin. Low-molecular-weight heparin is also frequently utilized, although results are largely divided. Data on aspirin remain equivocal. Studies on microvascular failure and flap loss have demonstrated little to no association with chemoprophylaxis. The evidence for postoperative thromboprophylaxis regimens in patients undergoing head and neck free tissue transfer is variable. Multiple studies have supported the use of unfractionated heparin or low-molecular-weight heparin. There appears to be an expert consensus for the combined use of mechanical prophylactic methods and chemical prophylaxis. Prospective randomized trials are required to validate the most effective combination of chemoprophylaxis agents.
Keywords: anticoagulation; head and neck surgery; microvascular surgery; thromboprophylaxis.
Conflict of interest statement
Figures
Similar articles
-
Chemoprophylaxis and Management of Venous Thromboembolism in Microvascular Surgery.Semin Plast Surg. 2023 Feb 9;37(1):57-72. doi: 10.1055/s-0042-1760381. eCollection 2023 Feb. Semin Plast Surg. 2023. PMID: 36776808 Free PMC article. Review.
-
Effects of aspirin and low-dose heparin in head and neck reconstruction using microvascular free flaps.Laryngoscope. 2005 Jun;115(6):973-6. doi: 10.1097/01.MLG.0000163539.97485.F4. Laryngoscope. 2005. PMID: 15933503 Review.
-
Antithrombotic Therapy for Venous Thromboembolism and Prevention of Thrombosis in Otolaryngology-Head and Neck Surgery: State of the Art Review.Otolaryngol Head Neck Surg. 2018 Apr;158(4):627-636. doi: 10.1177/0194599818756599. Epub 2018 Feb 27. Otolaryngol Head Neck Surg. 2018. PMID: 29484922 Review.
-
Head and Neck Microsurgeon Practice Patterns and Perceptions Regarding Venous Thromboembolism Prophylaxis.J Reconstr Microsurg. 2020 Oct;36(8):549-555. doi: 10.1055/s-0040-1710553. Epub 2020 May 14. J Reconstr Microsurg. 2020. PMID: 32408367
-
Unfractionated Heparin Administered Every 8 h Outperforms 12 Hourly Administration for Venous Thromboembolism Prophylaxis in Reconstructive Head and Neck Tumor Patients: A 12 Year Retrospective Cohort Study.Microsurgery. 2024 Nov;44(8):e31248. doi: 10.1002/micr.31248. Microsurgery. 2024. PMID: 39431625
Cited by
-
Impact of perioperative anticoagulation management on free flap survival in reconstructive surgery: a retrospective analysis.BMC Anesthesiol. 2025 Feb 26;25(1):106. doi: 10.1186/s12871-025-02975-6. BMC Anesthesiol. 2025. PMID: 40012031 Free PMC article.
-
Full versus Baby Dose Aspirin for Antithrombotic Prophylaxis in Free Tissue Transfer: Does Size Matter?Plast Reconstr Surg Glob Open. 2022 Dec 29;10(12):e4719. doi: 10.1097/GOX.0000000000004719. eCollection 2022 Dec. Plast Reconstr Surg Glob Open. 2022. PMID: 36601590 Free PMC article.
-
Delayed Reconstruction after Major Head and Neck Cancer Resection: An Interdisciplinary Feasibility Study.Cancers (Basel). 2023 May 16;15(10):2777. doi: 10.3390/cancers15102777. Cancers (Basel). 2023. PMID: 37345114 Free PMC article.
-
Venous Thromboembolism Prophylaxis in Maxillofacial Surgery.Cureus. 2024 Sep 24;16(9):e70077. doi: 10.7759/cureus.70077. eCollection 2024 Sep. Cureus. 2024. PMID: 39449906 Free PMC article. Review.
-
An animal experiment study on the application of indocyanine green angiography in the harvest of multi-angiosome perforator flap.Ann Transl Med. 2022 Feb;10(4):197. doi: 10.21037/atm-22-220. Ann Transl Med. 2022. PMID: 35280416 Free PMC article.
References
-
- Agnelli G. Prevention of venous thromboembolism in surgical patients. Circulation. 2004;110(24) 01:IV4–IV12. - PubMed
-
- Geerts W H, Pineo G F, Heit J Aet al.Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004126(3, Suppl):338S–400S. - PubMed
-
- Chen C M, Disa J J, Cordeiro P G, Pusic A L, McCarthy C M, Mehrara B J. The incidence of venous thromboembolism after oncologic head and neck reconstruction. Ann Plast Surg. 2008;60(05):476–479. - PubMed
-
- Clayburgh D R, Stott W, Cordiero T et al.Prospective study of venous thromboembolism in patients with head and neck cancer after surgery. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1143–1150. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous